Trilobio, developer of whole lab automation solutions for advancing biology research, today introduced the first version of its comprehensive robotics, lab equipment and software platform at the ...

Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges.NVIDIA collaborates with Thermo Fisher to ...

Autonomy, by contrast, is about decision‑making and adaptation. The leap from automation to autonomy is not just more actuators; it is a system that can perceive its environment, reason about options, ...

San Francisco, 06 May 2025: Trilobio, which is building an automated robotic lab-in-a-box for biologists, today announced it has raised $8 million USD Seed investment. The oversubscribed round was led ...

Explore the impact of drug discovery automation in 2026, addressing complexity and improving decision-making across ...

How AI, robotics, and modular design are transforming single-cell and spatial biology into scalable, precision-driven engines of discovery.

Advances in spatial biology enable scientists to visualize multiplexed biomolecules across multiple 'omics technologies at single-cell resolution. However, all of these technologies require ...

Today, the majority of cell biology operations are carried out manually, even though the core steps are highly reproducible. Staff are expected to conduct repetitive tasks for hours each day, and ...

DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, and Opentrons Labworks, Inc., a leader in lab automation and accessible robotics, announced a multi-year agreement ...

Artificial Intelligence (AI) is being viewed as a way to program automation in laboratories, which leaves questions about the relevance and impact of the role of automation specialists in light of ...

Trilobio, the Company building the fully automated robotic lab-in-a-box for biologists, today announced it has raised $8 million USD Seed investment. The oversubscribed round was led by Initialized ...